Submitted by Nivaldo Melo (nivaldo.melo@ufvjm.edu.br) on 2015-11-30T17:13:26Z No. of bitstreams: 2 nathale_rodrigues_pinheiro.pdf: 3567634 bytes, checksum: 502f3816acde8f2f1b1ee7fe24e188f1 (MD5) license_rdf: 23898 bytes, checksum: e363e809996cf46ada20da1accfcd9c7 (MD5) / Approved for entry into archive by Rodrigo Martins Cruz (rodrigo.cruz@ufvjm.edu.br) on 2015-12-03T16:14:53Z (GMT) No. of bitstreams: 2 nathale_rodrigues_pinheiro.pdf: 3567634 bytes, checksum: 502f3816acde8f2f1b1ee7fe24e188f1 (MD5) license_rdf: 23898 bytes, checksum: e363e809996cf46ada20da1accfcd9c7 (MD5) / Made available in DSpace on 2015-12-03T16:14:53Z (GMT). No. of bitstreams: 2 nathale_rodrigues_pinheiro.pdf: 3567634 bytes, checksum: 502f3816acde8f2f1b1ee7fe24e188f1 (MD5) license_rdf: 23898 bytes, checksum: e363e809996cf46ada20da1accfcd9c7 (MD5) Previous issue date: 2014 / Funda??o de Amparo ? Pesquisa do estado de Minas Gerais (FAPEMIG) / O sistema ADEPT (antibody-directed enzyme prodrug therapy) ? uma terapia antitumoral que envolve a ativa??o catal?tica de um pr?-f?rmaco, nas proximidades do s?tio tumoral, por uma enzima conjugada a um anticorpo monoclonal com afinidade para ant?genos espec?ficos das c?lulas tumorais. O sistema composto pela enzima Horseradish peroxidase (HRP) e ?cido indol-3-ac?tico (IAA) tem sido estudado para o emprego na terapia ADEPT, e associado ? indu??o de apoptose de c?lulas tumorais. A 2,4-pentanodiona (PD) tamb?m atua como substrato da HRP sendo oxidada por ela atrav?s de uma rea??o cuja cin?tica ? semelhante ? da cat?lise do IAA e, portanto, pode representar uma alternativa para essa terapia. Este trabalho teve como objetivo realizar uma avalia??o da citotoxicidade mediada pelos produtos provenientes da oxida??o da PD pela HRP frente a diferentes linhagens celulares, utilizando para isso diferentes metodologias que determinam a viabilidade celular como o azul de Trypan, MTT e vermelho neutro assim, como a an?lise microsc?pica das altera??es celulares induzidas por esses sistemas; estabelecer uma compara??o com a citotoxicidade mediada pela oxida??o do IAA catalisada pela mesma enzima; verificar a incid?ncia de morte celular por apoptose mediada pelos sistemas IAA/HRP/O2 e PD/HRP/O2; al?m de verificar a produ??o e os tipos de esp?cies reativas de oxig?nio (ERO) produzidas pelos dois sistemas. Os experimentos permitiram evidenciar que as combina??es PD/HRP/O2 e IAA/HRP/O2 levam a forma??o de ERO, sendo as esp?cies provavelmente formadas pela oxida??o da PD o radical ?nion super?xido e o per?xido de hidrog?nio (H2O2) e pela oxida??o do IAA o H2O2. Foi observado, somente para o IAA, um aumento na forma??o de ERO com o uso de uma maior concentra??o do substrato. Quanto ao estudo de viabilidade celular, esse permitiu evidenciar, atrav?s das tr?s metodologias, o efeito citot?xico dos sistemas PD/HRP/O2 e IAA/HRP/O2, no entanto, o ensaio do MTT mostrou-se mais sens?vel para esse estudo. A oxida??o do IAA pela HRP induziu apoptose, contudo n?o foi poss?vel identificar o tipo de morte celular mediada pelo sistema PD/HRP/O2, provavelmente devido a um problema t?cnico durante algumas an?lises em citometria de fluxo, o Quenhcing. Apesar de o sistema IAA/HRP/O2 ter apresentado uma destrui??o celular mais expressiva, o substrato IAA quando testado na aus?ncia da enzima mostrou-se t?xico, o que n?o foi visto para a PD quando testada nas concentra??es de 1; 1,5 e 2 mM, o que a torna um bom substrato para o emprego na terapia ADEPT. / Disserta??o (Mestrado) ? Programa de P?s-gradua??o em Ci?ncias Farmac?uticas, Universidade Federal dos Vales do Jequitinhonha e Mucuri, 2014. / ABSTRACT The system ADEPT (antibody-directed enzyme prodrug therapy) is an antitumor therapy that involves catalytic activation of a prodrug near the tumor site by an enzyme conjugated to a monoclonal antibody with affinity for specific antigens of tumor cells. The system composed by horseradish peroxidase (HRP) enzyme and indole-3-acetic acid (IAA) has been studied for the use in ADEPT therapy, and associated with apoptosis induction on tumor cells. The 2,4-pentanedione (PD) also acts as a substrate for HRP and being oxidized through a reaction whose kinetics is similar to the catalysis of IAA and, therefore, might represent an alternative to this therapy. This study aimed to conduct a evaluation of the cytotoxicity mediated by products from the oxidation of PD by HRP against different cell lines, using different methodologies that determine cell viability as Trypan blue, MTT and Neutral Red, as well as morphologic changes of the cell induced by these systems; establish a comparison with the cytotoxicity mediated by the oxidation of IAA catalyzed by the same enzyme; verify the incidence of apoptosis mediated by IAA/HRP/O2 and PD/HRP/O2 systems; besides verifying the production and types of reactive species oxygen (ROS) produced by the two systems. The experiments allowed to show that PD/HRP/O2 and IAA/HRP/O2 combinations lead to the formation of ROS, being the species probably formed by oxidation of PD the radical superoxide anion and hydrogen peroxide (H2O2) and by the oxidation of IAA the H2O2. It was observed only for the IAA, an increase in ROS production using a higher concentration of the substrate. Regarding the study of cell viability, this allowed to evidence, through the three methodologies, the cytotoxic effect of PD/HRP/O2 and IAA/HRP/O2 systems, however, the MTT assay proved more sensitive for this study. The oxidation of the IAA by HRP induced apoptosis, but could not identify the type of cell death mediated by PD/HRP/O2 system, The oxidation of by HRP the IAA induced apoptosis, but could not identify the type of cell death mediated by PD/HRP/O2 system, probably due to a technical problem for a few flow cytometric analyzes, the Quenching. Although IAA/HRP/O2 system have presented a more significant cell destruction, the IAA substrate when tested in the absence of enzyme was toxic, what has not seen for PD when tested in the concentrations of 1, 1.5, and 2 mM, making it a good substrate for employment in ADEPT therapy.